These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 32814898)

  • 1. C9orf72 in myeloid cells suppresses STING-induced inflammation.
    McCauley ME; O'Rourke JG; Yáñez A; Markman JL; Ho R; Wang X; Chen S; Lall D; Jin M; Muhammad AKMG; Bell S; Landeros J; Valencia V; Harms M; Arditi M; Jefferies C; Baloh RH
    Nature; 2020 Sep; 585(7823):96-101. PubMed ID: 32814898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD.
    Taminato T; Takeuchi T; Ueyama M; Mori K; Ikeda M; Mochizuki H; Nagai Y
    Hum Mol Genet; 2023 May; 32(10):1673-1682. PubMed ID: 36611007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
    Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
    J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
    Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
    Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
    Tomiyama H
    Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiogenomics of
    Bonham LW; Geier EG; Sirkis DW; Leong JK; Ramos EM; Wang Q; Karydas A; Lee SE; Sturm VE; Sawyer RP; Friedberg A; Ichida JK; Gitler AD; Sugrue L; Cordingley M; Bee W; Weber E; Kramer JH; Rankin KP; Rosen HJ; Boxer AL; Seeley WW; Ravits J; Miller BL; Yokoyama JS
    J Neurosci; 2023 Jan; 43(2):333-345. PubMed ID: 36446586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD.
    Esanov R; Cabrera GT; Andrade NS; Gendron TF; Brown RH; Benatar M; Wahlestedt C; Mueller C; Zeier Z
    Mol Neurodegener; 2017 Jun; 12(1):46. PubMed ID: 28606110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in
    Fujino Y; Ueyama M; Ishiguro T; Ozawa D; Ito H; Sugiki T; Murata A; Ishiguro A; Gendron T; Mori K; Tokuda E; Taminato T; Konno T; Koyama A; Kawabe Y; Takeuchi T; Furukawa Y; Fujiwara T; Ikeda M; Mizuno T; Mochizuki H; Mizusawa H; Wada K; Ishikawa K; Onodera O; Nakatani K; Petrucelli L; Taguchi H; Nagai Y
    Elife; 2023 Jul; 12():. PubMed ID: 37461319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
    Starr A; Sattler R
    Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia.
    Marques C; Held A; Dorfman K; Sung J; Song C; Kavuturu AS; Aguilar C; Russo T; Oakley DH; Albers MW; Hyman BT; Petrucelli L; Lagier-Tourenne C; Wainger BJ
    Acta Neuropathol; 2024 Mar; 147(1):56. PubMed ID: 38478117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
    Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
    Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model.
    Nguyen L; Montrasio F; Pattamatta A; Tusi SK; Bardhi O; Meyer KD; Hayes L; Nakamura K; Banez-Coronel M; Coyne A; Guo S; Laboissonniere LA; Gu Y; Narayanan S; Smith B; Nitsch RM; Kankel MW; Rushe M; Rothstein J; Zu T; Grimm J; Ranum LPW
    Neuron; 2020 Feb; 105(4):645-662.e11. PubMed ID: 31831332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains.
    Wang Q; Conlon EG; Manley JL; Rio DC
    Genome Res; 2020 Dec; 30(12):1705-1715. PubMed ID: 33055097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
    Farg MA; Konopka A; Soo KY; Ito D; Atkin JD
    Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD - a Systematic Review and Meta-Analysis.
    Kaliszewska A; Allison J; Col TT; Shaw C; Arias N
    Cerebellum; 2022 Aug; 21(4):681-714. PubMed ID: 34491551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.
    Ortega JA; Daley EL; Kour S; Samani M; Tellez L; Smith HS; Hall EA; Esengul YT; Tsai YH; Gendron TF; Donnelly CJ; Siddique T; Savas JN; Pandey UB; Kiskinis E
    Neuron; 2020 Apr; 106(1):90-107.e13. PubMed ID: 32059759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity.
    Xu W; Bao P; Jiang X; Wang H; Qin M; Wang R; Wang T; Yang Y; Lorenzini I; Liao L; Sattler R; Xu J
    Brain; 2019 May; 142(5):1349-1364. PubMed ID: 30938419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.